Treatment (Tx) patterns, efficacy and safety of eribulin for advanced and heavily pretreated breast cancer (ABC): A single-center, real-world study

被引：0
|
作者：
Yang, Jin [1 ]
Yang, Jiao [1 ]
Wang, Guangxi [1 ]
Zhang, Haochen [1 ]
Zhao, Shidi [1 ]
Zhao, Xiaoai [1 ]
Dong, Danfeng [1 ]
Wang, Le [1 ]
机构：
[1] Xi An Jiao Tong Univ, Dept Med Oncol, Affiliated Hosp 1, Xian, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e13118
引用
下载
收藏
页数：1
相关论文
共 50 条
  • [1] Treatment (Tx) patterns, efficacy and safety of eribulin for advanced and heavily pretreated breast cancer (ABC): Updated results from a single-center, real-world study.
    Yang, Jiao
    Ma, Xinyue
    Zhao, Shidi
    Zhao, Xiaoai
    Wang, Le
    Dong, Danfeng
    Yang, Jin
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [2] Real-world efficacy and safety of eribulin in advanced and pretreated HER2-negative breast cancer in a Spanish comprehensive cancer center
    Milana Bergamino Sirvén
    Adela Fernández-Ortega
    Agostina Stradella
    Idoia Morilla
    Catalina Falo
    Silvia Vázquez
    Roser Castany
    Rafael Villanueva
    Sabela Recalde
    Valentí Navarro Pérez
    Miguel Gil-Gil
    Sonia Pernas
    BMC Pharmacology and Toxicology, 20
  • [3] Real-world efficacy and safety of eribulin in advanced and pretreated HER2-negative breast cancer in a Spanish comprehensive cancer center
    Bergamino Sirven, Milana
    Fernandez-Ortega, Adela
    Stradella, Agostina
    Morilla, Idoia
    Falo, Catalina
    Vazquez, Silvia
    Castany, Roser
    Villanueva, Rafael
    Recalde, Sabela
    Navarro Perez, Valenti
    Gil-Gil, Miguel
    Pernas, Sonia
    BMC PHARMACOLOGY & TOXICOLOGY, 2019, 20 (01):
  • [4] Eribulin in heavily pretreated metastatic breast cancer: A real-world data from India
    Mandal, T. K.
    Bajpai, J.
    Kapoor, A.
    Kumar, A.
    Ghosh, J.
    Gulia, S.
    Rath, S.
    Gupta, S.
    ANNALS OF ONCOLOGY, 2020, 31 : S1264 - S1264
  • [5] Eribulin in Heavily Pretreated Metastatic Breast Cancer Patients in the Real World: A Retrospective Study
    Pedersini, Rebecca
    Vassalli, Lucia
    Claps, Melanie
    Tulla, Antonella
    Rodella, Filippo
    Grisanti, Salvatore
    Amoroso, Vito
    Roca, Elisa
    Simoncini, Edda Lucia
    Berruti, Alfredo
    ONCOLOGY, 2018, 94 : 10 - 15
  • [6] Real-world effectiveness of eribulin in heavily pretreated patients with metastatic breast cancer in China: a multicenter retrospective study
    Zhao, Yannan
    Xie, Ning
    Li, Wei
    Chen, Wenyan
    Lv, Zheng
    Zheng, Yabing
    Sun, Tao
    Liu, Jieqiong
    Zhang, Jian
    Hu, Shihui
    Wang, Yajun
    Gong, Chengcheng
    Li, Yi
    Xie, Yizhao
    Ge, Rui
    Xu, Fei
    Wang, Biyun
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2021, 13
  • [7] Efficacy and safety of eribulin monotherapy in patients with heavily pretreated metastatic breast cancer
    Ates, Ozturk
    Babacan, Taner
    Kertmen, Neyran
    Sarici, Furkan
    Cenoli, Alma
    Akin, Serkan
    Karakas, Yusuf
    Kilickap, Saadettin
    Ozisik, Yavuz
    Sever, Ali R.
    Aksoy, Sercan
    Altundag, Kadri
    JOURNAL OF BUON, 2016, 21 (02): : 375 - 381
  • [8] Real-world effectiveness of eribulin in heavily pretreated patients with metastatic breast cancer in China: A multicenter retrospective study.
    Zhao, Yannan
    Xie, Ning
    Li, Wei
    Chen, Wenyan
    Lv, Zheng
    Zheng, Yabing
    Sun, Tao
    Liu, Jieqiong
    Zhang, Jian
    Hu, Shihui
    Wang, Yajun
    Gong, C. C.
    Li, Yi
    Xie, Yizhao
    Ge, Rui
    Xu, Fei
    Wang, Biyun
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [9] Safety and efficacy of eribulin for "real-world" older patients with metastatic breast cancer
    de Nonneville, Alexandre
    Sabatier, Renaud
    Goncalves, Anthony
    Extra, Jean-Marc
    Tarpin, Carole
    Launay, Simon
    Tassy, Louis
    Viens, Patrice
    Rousseau, Frederique
    JOURNAL OF GERIATRIC ONCOLOGY, 2018, 9 (03) : 281 - 283
  • [10] Efficacy and safety of eribulin monotherapy in patients with heavily pretreated metastatic breast cancer.
    Ates, Ozturk
    Babacan, Taner
    Sarici, Furkan
    Kertmen, Neyran
    Cenoli, Alma
    Akin, Serkan
    Karakas, Yusuf
    Kilickap, Saadettin
    Aksoy, Sercan
    Ozisik, Yavuz Yasin
    Altundag, Kadri
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345